Comparing Safety and Efficacy of Combigan® and Lumigan® With Lumigan® Alone in Glaucoma or Ocular Hypertension Subjects Treated With Xalatan®

• Status: Completed
• Trial end date: 2010-09-01
• Target enrollment: 0
• Participant gender: All

Summary

Comparing Safety and Efficacy of Combigan® and Lumigan® with Lumigan® Alone in Glaucoma or Ocular Hypertension Subjects Treated with Xalatan®.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Allergan
• Treatments: Bimatoprost; Brimonidine Tartrate; Brimonidine Tartrate, Timolol Maleate Drug Combination; Maleic acid; Ophthalmic Solutions; Pharmaceutical Solutions; Tetrahydrozoline; Timolol

Criteria

Inclusion Criteria:

• Diagnosed with glaucoma or ocular hypertension.

• Visual Acuity 20/100 or better in both eyes

Exclusion Criteria:

• Any active ocular disease

• History of any intraocular surgery or glaucoma laser surgery within 3 months

• Contraindication to pupil dilation

• Use of topical, periorbital, intravitreal, or systemic steroid within 3 months